Information for "Pembrolizumab as well as nabpaclitaxel because save you therapy with regard to platinumtreated in your area advanced or even metastatic urothelial carcinoma temporary connection between the openlabel singlearm period The second PEANUT research"
From EECH Central
Basic information
| Display title | Pembrolizumab as well as nabpaclitaxel because save you therapy with regard to platinumtreated in your area advanced or even metastatic urothelial carcinoma temporary connection between the openlabel singlearm period The second PEANUT research |
| Default sort key | Pembrolizumab as well as nabpaclitaxel because save you therapy with regard to platinumtreated in your area advanced or even metastatic urothelial carcinoma temporary connection between the openlabel singlearm period The second PEANUT research |
| Page length (in bytes) | 3,385 |
| Page ID | 1308294 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Grousetoad0 (Talk | contribs) |
| Date of page creation | 09:52, 27 March 2024 |
| Latest editor | Grousetoad0 (Talk | contribs) |
| Date of latest edit | 09:52, 27 March 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
